In situ visualization of intratumor growth factor signaling: immunohistochemical localization of activated ERK/MAP kinase in glial neoplasms.
about
Inhibition of Nodal suppresses angiogenesis and growth of human gliomasOver-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosisIncreased phosphorylated extracellular signal-regulated kinase immunoreactivity associated with proliferative and morphologic lung alterations after chrysotile asbestos inhalation in miceMechanical trauma induces rapid astroglial activation of ERK/MAP kinase: Evidence for a paracrine signal.Phosphorylation state-specific antibodies: applications in investigative and diagnostic pathology.Androgen receptor phosphorylation: biological context and functional consequences.An extensive invasive intracranial human glioblastoma xenograft model: role of high level matrix metalloproteinase 9.Different accumulation of activated extracellular signal-regulated kinases (ERK 1/2) and role in cell-cycle alterations by epidermal growth factor, hydrogen peroxide, or asbestos in pulmonary epithelial cells.Physicochemical control of adult stem cell differentiation: shedding light on potential molecular mechanisms.The potential role of extracellular regulatory kinase in the survival of patients with early stage adenocarcinomaApoptosis and melanogenesis in human melanoma cells induced by anthrax lethal factor inactivation of mitogen-activated protein kinase kinaseExpression of SLP-2 was associated with invasion of esophageal squamous cell carcinoma.Synergistic inhibition of survival, proliferation, and migration of U87 cells with a combination of LY341495 and Iressa.The characteristics of astrocytomas and oligodendrogliomas are caused by two distinct and interchangeable signaling formats.Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathwaysActivation of mitogen-activated protein kinase is required for migration and invasion of placental site trophoblastic tumor.Extra-cellular signal-regulated ERK-1/ERK-2 pathway activation in human salivary gland mucoepidermoid carcinoma: association to aggressive tumor behavior and tumor cell proliferation.Mitogenic signal transduction pathways in meningiomas: novel targets for meningioma chemotherapy?Effects of MAP kinase inhibitors on epidermal growth factor-induced neoplastic transformation of human keratinocytes.Dual blockade of EGFR and ERK1/2 phosphorylation potentiates growth inhibition of breast cancer cells.ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours.New prospects for management and treatment of inoperable and recurrent skull base meningiomas.VEGF promotes gastric cancer development by upregulating CRMP4.Melatonin enhances sensitivity to fluorouracil in oesophageal squamous cell carcinoma through inhibition of Erk and Akt pathwayTherapeutic targets in malignant glioblastoma microenvironmentRosette forming glioneuronal tumor in association with Noonan syndrome: pathobiological implicationsTranscription factor 3 controls cell proliferation and migration in glioblastoma multiforme cell lines.Activation of mitogen-activated protein kinase extracellular signal-related kinase in head and neck squamous cell carcinomas after irradiation as part of a rescue mechanism.The GluR2 subunit inhibits proliferation by inactivating Src-MAPK signalling and induces apoptosis by means of caspase 3/6-dependent activation in glioma cells.Inhibition of c-Jun N-terminal kinase enhances temozolomide-induced cytotoxicity in human glioma cells.c-jun-NH2JNK mediates invasive potential and EGFR activation by regulating the expression of HB-EGF in a urokinase-stimulated pathway.Expression and modulation of the intermediate- conductance Ca2+-activated K+ channel in glioblastoma GL-15 cells.Up-regulation of fibronectin in oesophageal squamous cell carcinoma is associated with activation of the Erk pathway.PPARgamma-dependent effects of conjugated linoleic acid on the human glioblastoma cell line (ADF).Genetic alterations of the NRP/B gene are associated with human brain tumors.Malignant transformation of melanocytes to melanoma by constitutive activation of mitogen-activated protein kinase kinase (MAPKK) signaling.Fluorescent cascade and direct assays for characterization of RAF signaling pathway inhibitors.Elevated JNK activation contributes to the pathogenesis of human brain tumors.Interference with the constitutive activation of ERK1 and ERK2 impairs EWS/FLI-1-dependent transformation.Immunohistochemical characterization of canine neuroepithelial tumors.
P2860
Q24309876-3738CA70-4ABA-4F5F-B552-2523400AEC8BQ24805089-4C80BA44-1AF9-4BC2-8DE1-0769BCCB516EQ28344105-14A0F730-085A-41CA-A699-EC1DB2414754Q30307417-331A58C5-72A7-497A-B168-0AFE869C641DQ30311912-BFF92048-FC5D-4323-B89B-F640F1410E39Q30394055-9B18FFEA-4E71-47AF-9187-BFA2C0EB6647Q30432036-8C7680A3-D8C7-4718-AB0F-F36EABFFC497Q30663488-10421F50-AF8D-4F22-B031-D4454D0AA671Q33773343-A623F1F6-DF36-4751-8C41-0CFFDDDB2042Q33995206-F397AEAF-B5CC-4499-A7E1-22062F9C87D2Q34016286-849C2C04-718D-4072-9B71-D6A7E19465C8Q34718475-E92529E6-4F95-4AF1-9A02-076CDD7355CCQ34749647-DD9CBA55-E7C0-4D8C-BF82-82800E676981Q34768422-4ADF2EA4-E1B5-4561-8B4E-C429122E5C19Q35054868-9C49FDAF-5209-4B82-ACE0-A79AB38EC671Q35221788-781AD75B-89CD-4A5D-B360-2262C31F6281Q35791891-4817B615-8FD0-41B1-88CF-E9F299446DCAQ36327729-B3EAA9FB-8C77-4E61-8E36-95A81BE2EA13Q36430224-C03043BA-EA1F-4044-A553-CA37F55F853BQ36626059-CA9DF9F8-7C77-4D5A-97EA-7736EA59EAF7Q36694670-BE24B769-E3F7-46D6-9F6E-AE6D2EB42BE0Q36877009-5F0374C6-37A4-49E6-B1ED-1B8954E48738Q37086205-D43C428A-C265-41D1-8A6A-FE39C96454A8Q37465949-4B733E62-978B-4698-81B3-8DBD8D94C1E7Q37493413-C5849E89-5D46-41B5-806F-E2E248B2C558Q37947413-2CA424BF-470E-4791-AA2C-0A8FFCB36830Q38776234-E4C29F64-67BE-40DF-AA43-FB2AA3168107Q39471953-A9F27857-5D37-4961-9272-EA91FFFDDA7FQ39832584-FE7F88B2-A648-4499-A81F-D8B83435BB51Q39839523-D7AB83B1-9461-4639-893C-8A1114C6B35AQ40102284-DF48AC06-BE1E-4228-9B1D-7B57F8F44907Q40242625-79D434C7-A5E6-454F-AB82-11FF4FE9DBF1Q40374327-C4A916BD-55C1-4B95-8A23-FE462B990A96Q40403724-0CDCF02D-9F51-4C9F-9F3B-3B058A494494Q40543091-79D6BDD9-3252-45AF-8FA4-9CA0D2736FDFQ40679352-FC8FD0F0-B3CD-411A-86F3-0E8DC05A4C0EQ41763132-9DDE247E-770D-410A-AEFC-D472E61A9B6DQ42524158-4D0E2ED7-06FD-496E-9847-C3D8346DB604Q42795900-14C76DDB-B714-4AA4-8DBE-D674598F81E8Q43086056-CE315D79-3E87-40A4-ABA0-37DFE1CA7FED
P2860
In situ visualization of intratumor growth factor signaling: immunohistochemical localization of activated ERK/MAP kinase in glial neoplasms.
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
In situ visualization of intra ...... MAP kinase in glial neoplasms.
@ast
In situ visualization of intra ...... MAP kinase in glial neoplasms.
@en
type
label
In situ visualization of intra ...... MAP kinase in glial neoplasms.
@ast
In situ visualization of intra ...... MAP kinase in glial neoplasms.
@en
prefLabel
In situ visualization of intra ...... MAP kinase in glial neoplasms.
@ast
In situ visualization of intra ...... MAP kinase in glial neoplasms.
@en
P2093
P2860
P1476
In situ visualization of intra ...... MAP kinase in glial neoplasms.
@en
P2093
I M Hussaini
J W Mandell
S R VandenBerg
P2860
P304
P356
10.1016/S0002-9440(10)65728-8
P407
P577
1998-11-01T00:00:00Z